Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.

Publication

Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.

Journal Paper/Review - Jul 17, 2023

RAF and RENO-EXTEND Investigators*, Dittrich Tolga

Citation

RAF and RENO-EXTEND Investigators*, Dittrich T. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. Eur Stroke J 2023:23969873231183211.

Type

Journal Paper/Review (English)

Journal

Eur Stroke J 2023

Publication Date

Jul 17, 2023

Issn Electronic

2396-9881

Pages

23969873231183211

Brief description/objective

Ischaemic stroke patients with atrial fibrillation (AF) are at high risk of stroke recurrence despite oral anticoagulation therapy. Patients with cardiovascular comorbidities may take both antiplatelet and oral anticoagulation therapy (OAC/AP). Our study aims to evaluate the safety and efficacy of OAC/AP therapy as secondary prevention in people with AF and ischaemic stroke.